AN2 Therapeutics, Inc. - Common Stock

AN2 Therapeutics, Inc. - Common Stock Share · US0373261058 · ANTX (XNAS) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of AN2 Therapeutics, Inc. - Common Stock
Analyst Grade Summary
gauge-img
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
5
3
0
0
No Price
01.05.2026 20:00
Current Prices from AN2 Therapeutics, Inc. - Common Stock
ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
ANTX
USD
01.05.2026 20:00
4,68 USD
0,13 USD
+2,86 %
IEXG: IEX
IEX
ANTX
USD
01.05.2026 19:59
4,66 USD
0,11 USD
+2,42 %
Share Float & Liquidity
Free Float 56,55 %
Shares Float 15,5 M
Shares Outstanding 27,4 M
Company Profile for AN2 Therapeutics, Inc. - Common Stock Share
AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menlo Park, California.

Company Data

Name AN2 Therapeutics, Inc. - Common Stock
Company AN2 Therapeutics, Inc.
Symbol ANTX
Website https://www.an2therapeutics.com
Primary Exchange XNAS NASDAQ
ISIN US0373261058
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Eric E. Easom
Market Capitalization 128 Mio
Country United States of America
Currency USD
Employees 0,0 T
Address 1800 El Camino Real, 94027 Menlo Park
IPO Date 2022-03-25
Dividends from 'AN2 Therapeutics, Inc. - Common Stock'
Ex-Date Dividend per Share
12.04.2018 0,66 USD
11.01.2018 0,66 USD
12.10.2017 0,66 USD
12.07.2017 0,66 USD
11.04.2017 0,66 USD
11.01.2017 0,66 USD
12.10.2016 0,66 USD
13.07.2016 0,66 USD
13.04.2016 0,66 USD
13.01.2016 0,66 USD

ID Changes

Date From To
14.05.2015 ANMTU ANTX

Ticker Symbols

Name Symbol
NASDAQ ANTX
More Shares
Investors who hold AN2 Therapeutics, Inc. - Common Stock also have the following shares in their portfolio:
TASEKO MNS LTD
TASEKO MNS LTD Share
THAMES WATER UT.14/25 MTN
THAMES WATER UT.14/25 MTN Bond